tiprankstipranks
Trending News
More News >
Rapid Dose Therapeutics Corp (TSE:DOSE)
:DOSE
Canadian Market
Advertisement

Rapid Dose Therapeutics Corp (DOSE) Financial Statements

Compare
7 Followers

Rapid Dose Therapeutics Corp Financial Overview

Rapid Dose Therapeutics Corp's market cap is currently C$25.26M. The company's EPS TTM is C$; its P/E ratio is ―; Rapid Dose Therapeutics Corp is scheduled to report earnings on June 28, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 25Mar 24Mar 23Mar 22Mar 21
Income Statement
Total RevenueC$ 2.09MC$ 1.02MC$ 718.30KC$ 1.75MC$ 755.20K
Gross ProfitC$ 1.18MC$ 563.41KC$ 372.40KC$ 1.34MC$ 699.85K
Operating IncomeC$ 5.40MC$ -3.74MC$ -3.81MC$ -4.43MC$ -1.78M
EBITDAC$ -3.93MC$ -3.02MC$ -2.92MC$ -7.59MC$ -987.00K
Net IncomeC$ -5.40MC$ -4.31MC$ -3.81MC$ -8.49MC$ -1.80M
Balance Sheet
Cash & Short-Term InvestmentsC$ 20.72KC$ 161.06KC$ 27.59KC$ 34.44KC$ 70.26K
Total AssetsC$ 1.63MC$ 1.89MC$ 2.25MC$ 3.07MC$ 3.83M
Total DebtC$ 2.61MC$ 2.45MC$ 1.61MC$ 1.17MC$ 2.06M
Net DebtC$ 2.59MC$ 2.29MC$ 1.58MC$ 1.14MC$ 1.99M
Total LiabilitiesC$ 6.84MC$ 5.04MC$ 4.92MC$ 2.82MC$ 5.41M
Stockholders' EquityC$ -5.21MC$ -3.16MC$ -2.67MC$ 251.56KC$ -1.58M
Cash Flow
Free Cash FlowC$ -1.15MC$ -2.29MC$ -863.92KC$ -3.04MC$ -1.63M
Operating Cash FlowC$ -1.15MC$ -2.29MC$ -863.92KC$ -3.00MC$ -1.62M
Investing Cash FlowC$ -5.74KC$ 0.00C$ 0.00C$ 1.85MC$ -9.12K
Financing Cash FlowC$ 1.01MC$ 2.43MC$ 856.53KC$ 1.13MC$ 1.65M
Currency in CAD

Rapid Dose Therapeutics Corp Earnings and Revenue History

Rapid Dose Therapeutics Corp Debt to Assets

Rapid Dose Therapeutics Corp Cash Flow

Rapid Dose Therapeutics Corp Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis